Skip to main content

Find Clinical Trials

Home
Conditions
Myeloma

Clinical trial condition

Myeloma

Explore clinical trials studying Myeloma. Study availability and eligibility vary by location and protocol.

115 public trials 23 recruiting studies

Refine in advanced search Browse all conditions

Myeloma trial results

Recruiting

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

NCT04268199

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

View Trial Details

Recruiting

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

NCT06518551

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma

NCT06947083

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)

NCT07202091

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)

NCT07202078

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)

NCT07202065

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

NCT07202052

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

HEME Home Transfusion Program

NCT06487247

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancy, +14 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma

NCT07106671

Conditions: CRS - Cytokine Release Syndrome, Cytokine Release Syndrome, Inflammation, +8 more
Locations: Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)

NCT06430736

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Insel Gruppe AG Bern, Canton of Bern, Switzerland

View Trial Details